More than half of all global COVID-19 deaths reported over the last week were found in the Americas—reporting more than 1.3 million new cases and 37,000 deaths,
All eyes are on the fate of the AstraZeneca vaccine today, with EU drug regulators set to announce their findings about possible links between the jab and rare blood clots,
A 2018 surge in Lassa virus cases in Nigeria led the Federal Medical Centre in Owo to set up a special Lassa ward—and to launch a prospective cohort study of 510 hospitalized Lassa fever patients.
After noticing mothers suffering in silence, Haitian women are opening up the conversation around autism in their communities.
6 months after a COVID-19 diagnosis, 1 in 3 patients are diagnosed with a neuropsychiatric condition, according to a large
Our immune response to SARS-CoV-2 centers on the virus’s spike protein. All 3 COVID vaccines authorized in the US are based on a modified version of spike called 2P. A new, more resilient version called HexaPro may be even better.
Liberia is the first African country to introduce the new typhoid conjugate vaccine, folding it into routine immunizations for 9-month-olds, the
It’s not impossible to get infected with SARS-CoV-2 from contaminated surfaces—but the risk is extremely low—less than 1 in 10,000, the CDC confirmed yesterday,
Behind so many COVID-19 deaths: The children who’ve lost parents to the disease—nearly 40,000 of them in the US alone, according to a new
A speedy vaccine rollout is Bangladesh’s shining victory during the pandemic, but there aren’t enough takers for the shots, says Taufique Joarder, MBBS, DrPH, MPH, executive director of the Public Health Foundation, Bangladesh. Even as the country negotiated quick access to…